This articleneeds additional citations forverification. Please helpimprove this article byadding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Sulfafurazole" – news ·newspapers ·books ·scholar ·JSTOR(August 2014) (Learn how and when to remove this message) |
![]() | |
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
MedlinePlus | a601049 |
Pregnancy category |
|
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Excretion | Excreted unchanged in urine |
Identifiers | |
| |
CAS Number |
|
PubChemCID | |
DrugBank |
|
ChemSpider | |
UNII | |
KEGG |
|
ChEMBL | |
CompTox Dashboard(EPA) | |
ECHA InfoCard | 100.004.418![]() |
Chemical and physical data | |
Formula | C11H13N3O3S |
Molar mass | 267.30 g·mol−1 |
3D model (JSmol) | |
Melting point | 194 °C (381 °F) |
| |
| |
![]() ![]() |
Sulfafurazole (INN, also known assulfisoxazole) is asulfonamideantibacterial with a dimethyl-isoxazole substituent. It possessesantibiotic activity against a wide range ofGram-negative andGram-positive organisms.[1] It is sometimes given in combination witherythromycin (seeerythromycin/sulfafurazole) orphenazopyridine. It is used locally in a 4% solution orointment.
![]() | This systemicantibiotic-related article is astub. You can help Wikipedia byexpanding it. |